FDA Premarket Regulation of Tissue-Engineered Replacement Parts for Humans
MetadataShow full item record
CitationFDA Premarket Regulation of Tissue-Engineered Replacement Parts for Humans (2003 Third Year Paper)
AbstractThis paper is a description of tissue-engineered products, their potential for replacing conventional approaches to missing or failing tissues and organs, and FDAâ€™s ongoing efforts to develop a comprehensive and uniform scheme for regulating them.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:8965598
- HLS Student Papers